Confluent Medical Technologies, Fremont, California, announced the opening of its Nitinol Wire Center of Excellence in Hyderabad, India on May 4, 2026 — the opening day of the SMST 2026 Conference and Exposition in La Jolla. The new 26,000-square-foot facility doubles the company’s nitinol wire output and provides a dedicated location for nitinol wire manufacturing, allowing Confluent’s Fremont, California, location to focus on nitinol tubing.
The facility is ISO 13485 compliant and offers four-week lead times for wire diameters from 0.004 in. to 0.100 in., with ultra-tight tolerances down to ±0.0002 in. The investment is the latest step in a multi-year program to vertically integrate Confluent’s nitinol supply chain, which already includes melt and conversion partnerships, premium tubing, drawn wire, components, and finished medical-device assemblies.
“Opening our Nitinol Wire Center of Excellence in Hyderabad marks an important milestone in Confluent’s continued investment in a resilient, vertically integrated nitinol supply chain,” said Dean Schauer, chief executive officer, president, and chairman of Confluent Medical Technologies. “This facility expands our global manufacturing capacity and strengthens our ability to support the industry with the highest quality of nitinol material.”
Confluent Medical Technologies is a global contract development and manufacturing organization specializing in nitinol components and complex medical device assemblies. The company serves cardiovascular, structural heart, neurovascular, peripheral vascular, and other minimally invasive markets, with manufacturing operations in Fremont, California, and now Hyderabad, India.
